ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

The Promise of Ketamine as a Rapid-Acting Antidepressant

Lutz, Florida USA (Newsworthy.ai) Saturday Apr 22, 2023 @ 7:00 AM Pacific —

Ketamine is a medication that has been used for decades as an anesthetic agent, but new research is unveiling its potential as a rapid-acting antidepressant.

Depression is a mental health condition that affects millions of individuals worldwide. The current medications used to treat it, such as SSRIs, can take weeks or months before patients start seeing any benefits. However, research into the potential of Ketamine as a rapid-acting antidepressant is pointing to very promising results.

According to recent studies, the administration of low doses of Ketamine intravenously has been shown to relieve depressive symptoms within hours of being given to patients. More encouragingly, remission of symptoms may last up to one week, giving doctors and researchers additional time to develop long-term treatment plans alongside traditional therapies.

While more research and clinical trials are needed, the results obtained until now show that Ketamine could be a highly beneficial treatment for the millions of individuals currently suffering from depression. These findings could represent a major turning point in how doctors and researchers approach the treatment of depression.

The rapid-acting nature of Ketamine could make a tremendous impact on the lives of people suffering from depression.

The promising results of Ketamine for the treatment of depression have opened the door for further research and clinical trials. If successful, Ketamine could be a revolutionary treatment for depression and offer new hope for the millions of people affected by this condition.

About Turning Point Wellness Center

Turning Point Wellness Center is dedicated to providing innovative and effective solutions to help patients improve their mental and physical well-being. At Turning Point, we specialize in providing Ketamine treatments as an alternative to traditional psychiatric medications. We believe that patients deserve to have access to safe and effective treatments without the negative side effects associated with prescription drugs. In addition to Ketamine, we also offer hydration and nutrient IV therapy.



This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News at the speed of influence™. Reference URL for this press release is here.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.